Cytori Therapeutics Inc (NASDAQ:CYTX)

CAPS Rating: 1 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

CYTX News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

177 Outperform
35 Underperform
 

All-Star Players

16 Outperform
18 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top CYTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

JGGardner (< 20)
Submitted February 17, 2010

The Regenerative Medicine market is expected to grow to $3 billion by 2015. Cytori Therapeutics (CYTX) is the early leader in this market and is now treating, on a daily basis, more patients than any competing stem cell company. Given the large… More

zzlangerhans (99.78)
Submitted December 19, 2016

I just reviewed Cytori for the first time in a year and a half, and that's two hours of my life I won't be getting back. The company and stock are doomed in the long-term, but there's just enough chance of some ridiculous claim or manipulation to… More

CYTX VS S&P 500 (SPY)

Fools bullish on CYTX are also bullish on:

Fools bearish on CYTX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CYTX.

Recs

1
Member Avatar zzlangerhans (99.78) Submitted: 12/19/2016 4:44:03 PM : Underperform Start Price: $1.59 CYTX Score: +99.28

I just reviewed Cytori for the first time in a year and a half, and that's two hours of my life I won't be getting back. The company and stock are doomed in the long-term, but there's just enough chance of some ridiculous claim or manipulation to make the short unpleasantly high-risk. Therefore, untradeable. Cytori downplays their low and static revenues with an enormous amount of handwaving about various trials in progress and big future plans but the fact is their claimed successes have never translated into anything except quarterly losses and eroding shareholder value. I don't expect 2017 to be any different.

Recs

1
Member Avatar spiritof78 (96.64) Submitted: 8/14/2016 8:49:56 PM : Underperform Start Price: $2.04 CYTX Score: +106.96

Still going to zero

Recs

0
Member Avatar BillStacker (< 20) Submitted: 7/3/2013 9:07:52 PM : Outperform Start Price: $35.70 CYTX Score: -161.49

Made a good move with the new loan to sustain them for a while. I think the stock has bottomed and is ready to rebound.

Leaderboard

Find the members with the highest scoring picks in CYTX.

Score Leader

hwyman64

hwyman64 (< 20) Score: +271.06

In time this stock will be worth worth actually sinking some money into.....not quite ready to join the bandwagon yet though.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
hwyman64 < 20 10/9/2008 Underperform 1Y $59.85 -99.54% +171.52% +271.06 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $49.80 -99.45% +153.17% +252.62 0 Comment
Korodas 83.76 9/1/2010 Underperform NS $71.55 -99.62% +143.40% +243.02 0 Comment
udlilmike 80.96 2/2/2010 Underperform 1Y $105.60 -99.74% +141.29% +241.03 0 Comment
UltraContrarian 30.63 11/12/2009 1/25/2010 Underperform 5Y $50.85 -99.46% +141.07% +240.53 0 Comment
smax1980 25.84 12/8/2009 Underperform 5Y $92.10 -99.70% +140.17% +239.87 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $92.10 -99.70% +138.11% +237.81 0 Comment
GoldDontGlitter 52.38 12/7/2009 Underperform 5Y $93.45 -99.71% +137.70% +237.40 0 Comment
39272x2 < 20 12/1/2009 Underperform 5Y $90.00 -99.69% +137.68% +237.37 0 Comment
SwingingBridge 96.79 12/11/2009 Underperform 5Y $99.00 -99.72% +137.27% +236.99 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackascendiantc < 20 2/20/2013 Outperform NS $41.25 -36.00% +25.57% -61.57 8/6/2014 @ $26.40 0 Comment
TrackMaximGroup 64.57 9/7/2012 Outperform NS $49.05 -99.44% +83.06% -182.50 0 Comment
TrackZacks < 20 11/11/2008 Outperform 3M $45.15 +27.24% +53.90% -26.66 11/9/2012 @ $57.45 1 Comment
TrackZacks < 20 6/24/2008 Outperform 3M $101.70 -35.55% -24.24% -11.31 10/20/2008 @ $65.55 1 Comment
TrackRodmanRen < 20 1/2/2008 Outperform NS $93.45 -5.14% -23.50% +18.37 12/21/2009 @ $88.65 0 Comment
TrackBroadpointAmTech < 20 12/12/2007 Outperform NS $81.00 -59.81% -8.60% -51.22 4/17/2012 @ $32.55 0 Comment
TrackStanfordRes < 20 10/9/2007 Outperform NS $94.80 -65.66% -11.27% -54.40 4/17/2012 @ $32.55 0 Comment

Featured Broker Partners